Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rev Pneumol Clin ; 72(3): 163-70, 2016 May.
Artículo en Francés | MEDLINE | ID: mdl-27113617

RESUMEN

INTRODUCTION: The French college of general hospital respiratory physicians (CPHG) has conducted 10 years apart two prospective observational studies to assess changes in the primary lung cancer epidemiology and outcomes, including 1-year mortality. METHODS: In 2000 and 2010, all volunteer adult patients followed in the respiratory department of general hospitals participating in the study were consecutively included if their lung cancer was histologically or cytologically diagnosed between 01 January and 31 December (sample date). Their vital status at least 1 year after inclusion and date of death (if applicable) were collected. RESULTS: Respectively, 5667 and 7051 patients were included in the study in 2000 and 2010 and vital status of 5441 (96.0%) and 6981 (99%) patients known. One-year mortality rate was 61.8% in 2000 and 56.4% in 2010 (P<0.0001). Mortality rate significantly decreased from 2000 to 2010 in non-small-cell lung cancer (60.7% vs. 55.2%; P<0.0001) but not in small-cell lung cancer (66.9% vs. 64.2%; P=0.22). The year of diagnosis was an independent risk factor of mortality (OR=0.84; 95% CI: 0.77-0.91; P<0.0001). CONCLUSION: Although it remains low (43.6% in 2010), life expectancy at 1 year for patients with lung cancer has improved in 10 years. Five-year results are expected to show whether this improvement is maintained or not over time.


Asunto(s)
Neoplasias Pulmonares/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Pulmón de Células no Pequeñas/terapia , Femenino , Francia/epidemiología , Hospitales Generales , Humanos , Esperanza de Vida , Neoplasias Pulmonares/terapia , Masculino , Persona de Mediana Edad , Mejoramiento de la Calidad/tendencias , Carcinoma Pulmonar de Células Pequeñas/mortalidad , Carcinoma Pulmonar de Células Pequeñas/terapia , Fumar/epidemiología , Análisis de Supervivencia
2.
Rev Mal Respir ; 22(6 Pt 2): 8S106-11, 2005 Dec.
Artículo en Francés | MEDLINE | ID: mdl-16340845

RESUMEN

The techniques of interventional bronchoscopy have acquired an important place in the management of lung cancer. Techniques to relieve obstruction requiring the use of rigid bronchoscopy under general anaesthetic were the first to be introduced. Laser therapy, which was initially used for coagulation can be replaced by electrocautery. The development of endobronchial stents provides a natural complement to techniques aimed at clearing bronchial obstruction by helping to maintain patency in the long term. Other therapeutic techniques can be deployed in association with those already mentioned, including photodynamic therapy and brachytherapy using low doses of radiation applied locally. These have particular potential for the treatment of early disease. Questions remain as to the precise indications for the different techniques and of how to identify which approach is most appropriate for individual patients.


Asunto(s)
Broncoscopía/métodos , Neoplasias Pulmonares/cirugía , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA